Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS)

References

• Zhai Y-L, Nikaido T, Toki T, Shiozwawa A, Orii A, Fujii S. Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus. Br J Cancer 1999; 80: 1658–64.
   Google Scholar
• Mittal K, Demopoulos RI. MIB-1 (KI-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors. Human Pathol 2001; 32: 984–7.
   PubMed Web of Science ®Google Scholar
• Clement PB. The pathology of uterine smooth muscle tumors and mixed endometrial stromal smooth muscle tumors: a selective review with emphasis on recent advances. Int J Gynecol Pathol 2000; 19: 39–55.
   Google Scholar
• Zaloudek CJ, Norris HJ. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blaustein’s Pathology of the Female Genital Tract. New York: Springer Verlag, 1994: 849–914.
   Google Scholar
• Schwartz Z, Dgani R, Lancet M, Kessler I. Uterine sarcoma in Israel: a study 104 cases. Gynecol Oncol 1985; 20: 354–63.
   PubMed Web of Science ®Google Scholar
• Evans HL, Chawla SP, Simpson C, Finn KP. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 1988; 62: 2239–47.
   Google Scholar
• Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO, Trope CG. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol 1995; 34: 797–802.
   PubMed Web of Science ®Google Scholar
• Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave processed formalin-fixed paraffin sections. J Pathol 1992; 168: 357–63.
   PubMed Web of Science ®Google Scholar
• Layfield LJ, Liu K, Dodge R, Barsky SH. Uterine smooth muscle tumors: utility of classification by proliferation, ploidity, and prognostic markers versus traditional histopathology. Arch Pathol Lab Med 2000; 124: 221–7.
   PubMedGoogle Scholar
• Chou CY, Huang SC, Tsai YC, Hsu KF, Huang KE. Uterine leiomyosarcoma has deregulated cell proliferation, but not increased microvessel density compared with uterine leiomyoma. Gynecol Oncol 1997; 65: 225–31.
   Google Scholar
• Zhai YL, Nikaido T, Shizawa T, Orii A, Fujii S. Expressions of cyclins and cyclin-dependent kinases in smooth muscle tumors of the uterus. Int J Cancer 1999; 84: 244–50.
   Google Scholar
• Zhai YL, Kobayashi Y, Mori A, Orii A, Nikaido T, Konishi I et al. Expression of steroid receptors, Ki-67, and p-53 in uterine leiomyosarcomas. Int J Gynecol Pathol 1999; 18: 20–8.
   PubMed Web of Science ®Google Scholar
• Amada S, Nakano H, Tsuneyoshi M. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p-53 expression, DNA flow cytometry, and muscle specific actins. Int J Gynecol Pathol 1995; 14: 134–42.
   Google Scholar
• Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathological study of 213 cases. Am J Surg Pathol 1994; 18: 535–58.
   PubMed Web of Science ®Google Scholar
• Mayerhofer K, Obermair A, Windbichler G, Petru E, Kainder A, Helfer L et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999; 74: 196–201.
   PubMed Web of Science ®Google Scholar
• Seshadri R, Leong AS, McCaul K, Firgaira FA, Setlur V, Horsfall DJ. Relationship between p53 gene abnormalities and other tumor characteristics in breast cancer prognosis. Int J Cancer 1996; 69: 135–41.
   PubMed Web of Science ®Google Scholar
• Rudolph P, Olsson H, Bonatz G, Ratjen V, Bolte H, Baldetorp B et al. Correlation between p53, c-erb B-2, and topoisomerase IIa expression, DNA ploidity, hormonal receptor status and proliferation in 356 node negative breast carcinomas: Prognostic implications. J Pathol 1999; 187: 207–16.
   PubMed Web of Science ®Google Scholar
• Dunton CJ, van Hoeven KH, Kovatich AJ, Oliver RE, Scacheri RQ, Cater JR et al. Ki-67 antigen staining as an adjunct to identifying cervical intraepithelial neoplasia. Gynecol Oncol 1997; 64: 451–5.
   PubMed Web of Science ®Google Scholar
• Jeffers MD, Oakes SJ, Richmond JA, Macaulay EM. Proliferation, ploidity and prognosis in uterine smooth muscle tumors. Histopathology 1996; 29: 217–23.
   PubMed Web of Science ®Google Scholar